目录
- Letter from the Editors-in-Chief
- New era of treatment and evaluation of traumatic brain injury and spinal cord injury
- Magnetic resonance imaging and cell-based neurorestorative therapy after brain injury
- A brief report on MRI investigation of experimental traumatic brain injury
- The potential of neural transplantation for brain repair and regeneration following traumatic brain injury
- RhoA/Rho kinase in spinal cord injury
- Direct reprogramming of somatic cells into neural stem cells or neurons for neurological disorders
- The progress in optic nerve regeneration, where are we?
- Glucocorticoids and nervous system plasticity
- SCYL pseudokinases in neuronal function and survival
- Unmasking the responses of the stem cells and progenitors in the subventricular zone after neonatal and pediatric brain injuries
- Tracking of iron-labeled human neural stem cells by magnetic resonance imaging in cell replacement therapy for Parkinson’s disease
- Macrophage polarization in nerve injury: do Schwann cells play a role?
- Spinal cord concussion: studying the potential risks of repetitive injury
- Promoting neuronal regeneration using extracellular vesicles loaded with superparamagnetic iron oxide nanoparticles
- Developmental transcription factors in age-related CNS disease: a phoenix rising from the ashes?
- The concentration game: differential effects of bioactive signaling in 2D and 3D culture
- Skeletal muscle activity and CNS neuro-plasticity
- Exploiting kinase polypharmacology for nerve regeneration
- Schwannomas provide insight into the role of p75NTRand merlin in Schwann cells following nerve injury and during regeneration
- Role of neuronal gap junctions in NMDA receptor-mediated excitotoxicity and ischemic neuronal death
- Lipid mediators of inflammation in neurological injury: shifting the balance toward resolution
- Nootropics with potential to (re)build neuroarchitecture
- Polarizing the immune system towards neuroprotection in brain ischemia
- Future needs for informed consent in stem cell clinical trials in neurodegenerative diseases
- How does resveratrol influence the genesis of some neurodegenerative diseases?
- Lingo-1: a novel target in therapy for Alzheimer’s disease?
- Mesenchymal stem cells require the peripheral immune system for immunomodulating effects in animal models of multiple sclerosis
- Absence of galectin-3 attenuates neuroinflammation improving functional recovery after spinal cord injury
- Neuroprotective effect of Shenqi Fuzheng injection pretreatment in aged rats with cerebral ischemia/ reperfusion injury
- Verbascoside promotes the regeneration of tyrosine hydroxylase-immunoreactive neurons in the substantia nigra
- Umbilical cord-derived mesenchymal stem cell transplantation combined with hyperbaric oxygen treatment for repair of traumatic brain injury
- Specific effects of c-Jun NH2-terminal kinaseinteracting protein 1 in neuronal axons
- Connectivity differences between adult male and female patients with attention deficit hyperactivity disorder according to resting-state functional MRI
- Does hemispheric lateralization influence therapeutic effects of transcranial direct current stimulation?
- Traumatic axonal injury of the medial lemniscus pathway in a patient with traumatic brain injury: validation by diffusion tensor tractography
- Spatiotemporal expression of Nogo-66 receptor after focal cerebral ischemia
- Time representation of mitochondrial morphology and function after acute spinal cord injury
- Treatment with analgesics after mouse sciatic nerve injury does not alter expression of wound healingassociated genes
- A novel bioactive nerve conduit for the repair of peripheral nerve injury
- Cerebrolysin improves sciatic nerve dysfunction in a mouse model of diabetic peripheral neuropathy
- Dexamethasone prevents vascular damage in earlystage non-freezing cold injury of the sciatic nerve
- Angiogenesis in tissue-engineered nerves evaluated objectively using MICROFIL perfusion and micro-CT scanning
- Vascular endothelial growth factor: an attractive target in the treatment of hypoxic/ischemic brain injury